Researchers have long known that patients who leave emergency departments before medically advised use more emergency care ...

Along with claiming the lives of 1.2 million Americans, the COVID-19 pandemic has been described as a mass disabling event.

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.

The following is a summary of “Identification of patient demographic, clinical, and SARS-CoV-2 genomic factors associated with severe COVID-19 using supervised machine learning: a retrospective ...

The Godley Independent School District in Godley, Texas, reported that its attendance was down to between 70% and 80% ...

Jan. 20, 2025, marks five years since the CDC reported the first laboratory-confirmed case of COVID-19 on American soil.

A cross-sectional analysis of 721 million emergency department visits found that 0.8% of patients left before medical ...

The same mechanisms involved in COVID-related cardiovascular events are responsible for COVID-related myocarditis.

Pulmonary fibrosis is a rare, chronic disease that causes scarring in the lungs, making breathing difficult for people who suffer with it. And, as University of South Florida pulmonologist Dr. Jose ...

Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.

Pulmonary fibrosis in patients with COVID-19 tends to resolve, while idiopathic pulmonary fibrosis always progresses.

Here is some info from Ohio State – improving lives through excellence in research, education and patient care.